Thank you for standing by, and welcome to the BBOT Clinical Data Update Call. Today's program is being recorded. [Operator Instructions] I'd now like to introduce your host for today's program, ...

In a pretreated population of participants with advanced/metastatic cancer and the majority with prior PD-(L)1 treatment, BHV-1510 2.5 mg/kg Q3W plus cemiplimab resulted in confirmed objective ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their launch of ‘Human Data Trials' - a new category of pre-clinical research ...

Effective treatment and prevention of cancer depends on early, consistent, and accurate reporting of cases. Doctors diagnosed nearly 2 million cases of cancer in the U.S. in 2022 alone – an average of ...

INDIANAPOLIS – After three action-packed days of competition at the USATF Para National Championships in Eugene, Ore., USA Track & Field today announced the 40 athletes that will represent the United ...

The Food and Drug Administration announced the approval of 127 innovator and biosimilar drugs in 2024, a notable decrease from the 149 approvals recorded in 2023. Despite the decline in overall ...

Katalyze AI launched Digityze AI, an AI-powered document intelligence platform for biomanufacturing and built natively on the Snowflake AI Data Cloud. The platform transforms unstructured documents ...

JERUSALEM, June 26, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced that new data exploring the dual ...

SOMERSET, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, a global leader in the comparator sourcing and clinical trial supplies, has launched NCE Grid, the world’s first free NCE-1 ...

(RTTNews) - Tourmaline Bio, Inc. (TRML), Tuesday reported positive topline results from its Phase 2 TRANQUILITY study evaluating pacibekitug in patients with elevated high-sensitivity C-reactive ...